Litigation Details for Celltrion, Inc. v. Genentech, Inc. (N.D. Cal. 2018)
✉ Email this page to a colleague
Celltrion, Inc. v. Genentech, Inc. (N.D. Cal. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-01-11 |
Court | District Court, N.D. California | Date Terminated | 2018-06-11 |
Cause | 28:1338 Patent Infringement | Assigned To | Jeffrey Steven White |
Jury Demand | None | Referred To | |
Parties | HOFFMANN-LA ROCHE INC. | ||
Patents | 7,449,184; 7,485,704; 7,807,799; 8,512,983; 8,691,232; 9,428,548; 9,714,293 | ||
Attorneys | Robert V. Cerwinski | ||
Firms | Goodwin Procter LLP, the New York Times Building | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Celltrion, Inc. v. Genentech, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Celltrion, Inc. v. Genentech, Inc. (N.D. Cal. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-01-10 | 1 | U.S. Patent No. 7,390,660 (“the ’660 patent”); 5 (xiii) U.S. Patent No. 7,449,184 (“the ’184 … 18 enforce the ’660 patent. 19 63. U.S. Patent No. 7,449,184 (Exhibit 13), titled “…Declaratory Judgment of Non-Infringement of U.S. Patent No. 7,449,184 19 215. Plaintiffs restate…Declaratory Judgment of Invalidity of U.S. Patent No. 7,449,184 15 221. Plaintiffs restate…claims of U.S. Patent Nos. 6,331,415; 6,339,142; 6,417,335; 9 6,610,516; 6,716,602; 7,449,184; 7,501,122 | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |